HMGCR and breast cancer: Indeed, higher basal transcript levels of this signature, which included HMGCR, predicted low sensitivity to statin therapy and correlated with poor prognosis after primary breast cancer diagnosis10, irrespective of estrogen receptor alpha (ER) status.